| [1] |
Rizvi S, Khan SA, Hallemeier CL, et al. Cholangiocarcinoma-evolving concepts and therapeutic strategies[J]. Nat Rev Clin Oncol, 2018, 15(2):95-111.
|
| [2] |
Chua D, Low A, Koh Y, et al. A retrospective review of correlative radiological assessment and surgical exploration for hilar cholangiocarcinoma[J]. Ann Hepatobiliary Pancreat Surg, 2018, 22(3):216-222.
|
| [3] |
Spolverato G, Kim Y, Alexandrescu S, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection[J]. Ann Surg Oncol, 2016, 23(1):235-243.
|
| [4] |
Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications[J]. Cell Res, 2021, 31(2):107-125.
|
| [5] |
Su Y, Zhao B, Zhou L, et al. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs[J]. Cancer Lett, 2020(483):127-136.
|
| [6] |
Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer[J]. J Hematol Oncol, 2019, 12(1):34.
|
| [7] |
Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm[J]. Cancer Res, 2017, 77(15):3965-3981.
|
| [8] |
Liu SJ, Dang HX, Lim DA, et al. Long noncoding RNAs in cancer metastasis[J]. Nat Rev Cancer, 2021, 21(7):446-460.
|
| [9] |
Salati M, Braconi C. Noncoding RNA in cholangiocarcinoma[J]. Semin Liver Dis, 2019, 39(1):13-25.
|
| [10] |
Merdrignac A, Papoutsoglou P, Coulouarn C. Long noncoding RNAs in cholangiocarcinoma[J]. Hepatology, 2021, 73(3):1213-1226.
|
| [11] |
Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations[J]. Database, 2020:baaa021.
|
| [12] |
Razumilava N, Gores GJ. Cholangiocarcinoma[J]. Lancet, 2014, 383(9935):2168-2179.
|
| [13] |
Sia D, Villanueva A, Friedman SL, et al. Liver cancer cell of origin, molecular class, and effects on patient prognosis[J]. Gastroenterology, 2017, 152(4):745-761.
|
| [14] |
Battaglia AM, Chirillo R, Aversa I, et al. Ferroptosis and cancer: mitochondria meet the "iron maiden" cell death[J]. Cells, 2020, 9(6): 1505.
|
| [15] |
Chen X, Kang R, Kroemer G, et al. Broadening horizons: the role of ferroptosis in cancer[J]. Nat Rev Clin Oncol, 2021, 18(5):280-296.
|
| [16] |
Viswanathan VS, Ryan MJ, Dhruv HD, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway[J]. Nature, 2017, 547(7664):453-457.
|
| [17] |
Mao C, Wang X, Liu Y, et al. A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53[J]. Cancer Res, 2018, 78(13):3484-3496.
|
| [18] |
Wang M, Mao C, Ouyang L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA[J]. Cell Death Differ, 2019, 26(11):2329-2343.
|
| [19] |
Gu ZR, Liu W. The LncRNA AL161431.1 targets miR-1252-5p and facilitates cellular proliferation and migration via MAPK signaling in endometrial carcinoma[J]. Eur Rev Med Pharmacol Sci, 2020, 24(5): 2294-2302.
|
| [20] |
Ma G, Li G, Fan W, et al. The role of long noncoding RNA AL161431.1 in the development and progression of pancreatic cancer[J]. Front Oncol, 2021(11):666313.
|
| [21] |
Jiang H, Xu A, Li M, et al. Seven autophagy-related lncRNAs are associated with the tumor immune microenvironment in predicting survival risk of nonsmall cell lung cancer[J]. Brief Funct Genomics, 2021, 21(3):177-187.
|